Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

An analysis of major depressive disorder, covering diagnostic criteria, prevalence statistics across demographics, and ...

A new systematic historical and meta-analytic review published in the Journal of Affective Disorders found inconsistent and ...

Eye movement desensitization and reprocessing (EMDR) sounds complicated, but the treatment itself is straightforward.

The risk for a diagnosis of epilepsy is more than two times greater for those with depression, although incidence is low, ...

Reinforcement Learning, Explainable AI, Computational Psychiatry, Antidepressant Dose Optimization, Major Depressive Disorder, Treatment Personalization, Clinical Decision Support Share and Cite: de ...

Moment of Clarity has released a new educational resource providing a detailed examination of the “benefits and limitations ...

Background: Precision medicine promises to improve treatment outcomes by tailoring interventions to patients’ individual characteristics. However, the use of precision medicine tools requires patient ...

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...

What Is Treatment-Resistant Depression (TRD)? Although a consensus is lacking, the most common definition—including the one that the US Food and Drug Administration (FDA) adopted—is depression that ...